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Abstract Cardiac resynchronization therapy is a
high cost therapeutic option with proven efﬁcacy on
improving symptoms of ventricular failure and for
reducing both hospitalization and mortality. How-
ever, a signiﬁcant number of patients do not respond
to cardiac resynchronization therapy that is due to
various reasons. Identiﬁcation of the optimal pacing
site is crucial to obtain the best therapeutic result that
necessitates careful patient selection. Currently, using
echocardiography for mechanical dyssynchrony
assessment performs patient selection. Multi-Detec-
tor-Row Computed Tomography (MDCT) and Mag-
netic Resonance Imaging (MRI) are new imaging
techniques that may assist the cardiologist in patient
selection. These new imaging techniques have the
potential to improve the success rate of cardiac
resynchronization therapy, due to pre-interventional
evaluation of the venous coronary anatomy, to
evaluation of the presence of scar tissue, and to
improved evaluation of mechanical dyssynchrony. In
conclusion, clinical issues associated with heart
failure in potential candidates for cardiac resynchro-
nization therapy, and the information regarding this
therapy that can be provided by the imaging
techniques echocardiography, MDCT, and MRI, are
reviewed.
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Introduction
Cardiac resynchronization therapy (CRT), obtained
by implanting a biventricular pacemaker, is an
established therapeutic option for patients with
reduced left ventricular ejection fraction (35%),
prolonged QRS interval (120 ms) and NYHA class
III/IV systolic heart failure (HF) despite optimal
medical therapy. CRT improves symptoms and
decreases both hospitalizations and mortality [1].
CRT is effective by reversing left ventricular (LV)
remodelling and increasing the ejection fraction
(EF), while correcting the main cause of LV
functional and morphologic disturbances, named
mechanical dyssynchrony, which is basically an
activation delay between cardiac chambers or LV
segments. LV reverse remodelling, deﬁned by a
reduction in end-systolic and end-diastolic diameters
and volumes has been referred as an indicator to
CRT response. However, between 20% and 30% of
patients do not respond to CRT [2]. Suggested
reasons include a prolonged QRS duration without
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due to mismatch between the LV lead position and
the most delayed myocardial region [2–4]. It has
been suggested that measuring mechanical dyssyn-
chrony by echocardiography may better identify
patients who are likely to respond to CRT [5].
Currently echocardiography has been used in selec-
tion and follow-up of candidates to CRT, namely in
the evaluation of LVEF and LV remodelling and
ventricular dyssynchrony. Multi-Detector-Row Com-
puted Tomography (MDCT) and Magnetic Reso-
nance Imaging (MRI) are increasingly used for
cardiac evaluation. MDCT and MRI allow depiction
of cardiac anatomy with high spatial resolution as
well as highly accurate measurements of cardiac
function [6–8]. In this review clinical issues con-
cerning CRT as well as clinical applications of these
three imaging modalities will be discussed.
Clinical issues
Left ventricular systolic dysfunction
and remodelling
Heart Failure (HF) and cardiomyopathy refer to a
spectrum of diseases that encompass various clinical
entities, where inadequate function of one or both
ventricles forms the basis of cardiac disease. Chronic
HF develops after injury or stress to the myocardium,
due to a variety of causes, e.g. ischemia, hyperten-
sion, valvular disease, myocarditis, etc. In compen-
satory response the heart remodels, leading to
changes in myocardial structure and neurohormonal
milieu of the entire cardiovascular system. Increased
wall stress leads to alterations in the geometry of the
heart, with hypertrophy or dilatation of the ventri-
cle(s) [9]. Increased LV size and decreased LVEF are
associated with increased neurohormonal activation
and predict prognosis. Also when class III or IV
symptoms and LVEF less than 30% are present,
LV dimension is considered a strong predictor of
mortality [10]. Moreover, right ventricular (RV)
dysfunction is also associated with increased mortal-
ity [11].
The effects of CRT can be divided into early and
long-term effects. Studies in the acute setting have
demonstrated that CRT abruptly increases LVEF with
improved energetic chamber efﬁciency [12–15]. The
main long-term CRT effect is the so-called ‘‘LV
reverse remodelling’’ [2, 5]. A 10% reduction in LV
end-systolic and end-diastolic volumes has been
associated with increased LVEF [16]. Even this
relatively small amount of LV reverse remodelling
has been shown to be a strong predictor for improved
survival and decrease of HF events [2, 15–17].
Diastolic dysfunction
Most HF are associated with an impaired LVEF
below 50% which is usually accompanied by dia-
stolic dysfunction [1]. However, 30–50% of HF
patients have LVEF of 50% or greater. These patients
are assumed to have diastolic dysfunction as the
primary mechanism of heart failure; however, dia-
stolic dysfunction is variably identiﬁed and diagnosed
[18]. The combined assessment of LV inﬂow,
pulmonary venous ﬁlling pattern and the mitral
annulus or basal ventricular myocardial velocities
allows identifying three characteristic abnormal dia-
stolic ventricular ﬁlling patterns: ‘‘impaired relaxa-
tion’’ ‘‘pseudonormalized ﬁlling’’, and ‘‘restrictive
ﬁlling’’ (Table 1) that represent increasing degrees of
diastolic dysfunction, respectively [1, 18–21]. The
impact of CRT on diastolic function is not fully
understood [22]. Nevertheless, it has been shown that
12 months after CRT, reverse remodelling was
accompanied by improvements of LV diastolic
function [23].
Mitral regurgitation
End-stage HF usually gives rise to mitral regurgita-
tion (MR) and the resulting LV volume overload
further deteriorates LV function, which in turn
increases MR [24]. Causes of MR include: (1)
Incomplete closure of the mitral valve leaﬂets due
to systolic retraction of the papillary muscles towards
the apex in the dilated LV [25]; (2) Papillary muscle
dysfunction due to wall motion abnormalities in the
inferior/posterior regions [26]; (3) LV dyssynchrony
[27] and (4) Incomplete mitral valve closure due to
prolonged AV interval with delayed LV contraction
that results in pre-systolic (diastolic) MR [28].
The severity of MR depends on LV dimensions
and correlates with outcome [29]. Signiﬁcant reduc-
tion in MR has been reported immediately as well as
late after CRT [17, 30, 31]. The immediate reduction
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the pre-systolic MR component by pacing with a
short (optimized) AV delay, and by improved coor-
dination of ventricular contraction, that included
resynchronized papillary muscle activation [16]. Late
reduction in MR has been observed months after CRT
and is probably related to LV reverse remodelling
[17].
Left ventricular electrical and mechanical
dyssynchrony
The QRS complex represents the vectorial sum of
electrical forces generated by myocardial masses
over time. Normal electrical activation propagates as
a uniform high-velocity wavefront through the myo-
cardial Purkinje network. In damaged myocardium,
altered conduction properties impair the velocity and
direction of electrical propagation [32]. Abnormal
ventricular depolarization, manifesting as QRS inter-
val prolongation 120 ms, also known as bundle
branch block, generates regions of both early and
delayed ventricular contraction. The delayed seg-
ments accommodate contractile forces and volume,
hereby reducing LV systolic function.
Increasing QRS interval duration is directly related
to impaired LVEF [33–35].
The prevalence of bundle branch block is about
20% in the general HF population [33, 34] and up to
35% among patients with more severely impaired
systolic function. QRS morphology and duration
depends on myocardial mass, but provide no infor-
mation concerning regional mechanical changes. In
failing myocardium, heterogeneous interstitial ﬁbro-
sis results in disorganized depolarization that causes
abnormal regional loading conditions, inducing fur-
ther localized ﬁbrosis and hypertrophy with conse-
quent mechanical dyssynchrony [36].
Although coupling of electrical activation and
mechanical contraction is not completely deﬁned,
there is convincing evidence of electromechanical
dissociation [32]. In myocardial ischemia, impaired
regional contractility and wall motion abnormalities
frequently produce mechanical dyssynchrony without
disturbing electrical conduction [32]. After electrical
activation, regional mechanical delays in time to peak
systolic velocity (Ts) occurs in addition to delays in
isovolumetric contraction [37]. Despite correlation
between QRS narrowing and CRT response [38–41],
haemodynamic studies indicate CTR beneﬁts relate
to improvements in mechanical rather than electrical
coordination [42–45].
Mechanical dyssynchrony may be considered in
terms of inter- and intraventricular components.
Interventricular dyssynchrony refers to delayed acti-
vation of the LV relative to the RV. Intraventricular
dyssynchrony refers to delayed activation of one LV
region relative to another. Because of ventricular
interdependence, correction of intraventricular dys-
synchrony frequently results in improvement of
interventricular dyssynchronization as well. QRS
interval duration alone has no correlation with
intraventricular dyssynchrony and only has a limited
relationship with interventricular dyssynchrony and
consistently fails to predict response to CRT [32].
Ischemic heart disease
In the United States, ischemic heart disease accounts
for 50–70% of HF. In patients who are potential
candidates for CRT, coronary artery risk stratiﬁcation
is often necessary to exclude myocardial revascular-
ization as therapeutic option. Ischemia worsens the
prognosis and this may be due to a higher incidence
of diabetes in the ischemic population [46]. It has
been demonstrated that one year after CRT, patients
with ischemic HF had less LV remodelling and
symptomatic improve than patients with non-ische-
mic heart failure [23]. In addition, patients with
ischemic HF have higher risk of sudden death.
Moreover, in patients who have a past history of
myocardial infarction, scarred tissue may complicate
Table 1 Abnormal
diastolic ventricular ﬁlling
patterns
Deceleration time
of E velocity (ms)
Isovolumetric
relaxation time (ms)
E
velocity
A
velocity
E/A
ratio
Impaired relaxation >240 >110 ;:<1.0
Pseudonormalization
ﬁlling
160–240 <90 :;1.0–
1.5
Restrictive ﬁlling <160 <70 :;>1.5
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whether LV pacing in a scarred region will be
beneﬁcial [5].
Coronary venous system
The cardiac venous system is currently gaining
interest. Two-dimensional (2D) transthoracic echo-
cardiography (TTE) allows visualization of the
coronary sinus, the gateway to LV transvenous lead
placement to achieve biventricular pacing. Although
the success rate for transvenous LV lead placement is
relatively high (88–95% in large clinical trials), the
procedure is not successful in 5–12% of patients [47].
Failure of LV lead placement has been attributed to
the inability to insert catheters in the coronary sinus
but also to the lack of suitable side branches [47, 48].
The coronary venous anatomy can be systemati-
cally evaluated in a form comparable to that estab-
lished by echocardiography and LV angiography for
the coronary artery system [49], adding information
concerning the course and dimensions of the coronary
veins and tributaries. It facilitates optimal LV lead
placement by identifying the vein or tributary that
corresponds to the site of latest LV myocardial
activation, the optimal pacing site for successful CRT
[50]. However, the most optimal CRT pacing site
may not always have a suitable vein. In particular,
identifying patients without suitable coronary veins
for pacemaker lead implantation is important as these
patients may be best treated by epicardial pacemaker
lead implantation that requires a minimal surgical
approach [48].
Echocardiography
General considerations
Echocardiography has been used in selection of
patients for CRT and their follow-up, namely in the
evaluation of LVEF, LV remodelling and mechanical
dyssynchrony. Although echocardiography has a
well-recognized value in general cardiac assessment
and is a widely available, non-invasive imaging
modality, the technique has certain limitations: (1) It
is a 2D technique where measures are obtained using
various views and geometrical models that may
provide sources of error; (2) The time needed to
perform extensive measurements may limit applica-
tion in routine clinical practice and (3) Reproducibil-
ity of acquired data may be limited by hemodynamic
variations, operator experience, machine settings,
available acoustic window, and angle of incidence
effects.
Echocardiography of left ventricular systolic
function
2D-TTE is used for qualitative and semi-quantitative
LV function evaluation. Global function is assessed,
measuring the degree of endocardial motion and
ventricular wall thickening for various cardiac seg-
ments and by integrating the information from
several tomographic planes. For evaluation of
regional function, the LV is divided into 17 segments
and regional wall motion is scored according to the
recommendations of American Society of Echocar-
diography (ASE) [51]. The accuracy of qualitatively
estimating EF largely depends on the experience of
the reader (an experienced reader estimates LVEF in
intervals of 5–10%), and also depends on the acoustic
window that renders up to 10% of the endocardial
borders inadequate. Quantitative assessment involves
geometrical assumptions and formulas. The most
often used is the modiﬁed Simpson ´s rule to calculate
LVEF. EF is calculated as EF = 100 · (EDVESV)/
EDV, where EDV and ESV are the end-diastolic and
end-systolic volumes, respectively, obtained from
endocardial border detection in four-chamber view
and two-chamber view at end-diastole and end-
systole [52]. This method has some limitations that
include the possibility of incorrect endocardial border
detection, and LVEF calculations that cannot be
corrected for mitral or aortic regurgitation.
Echocardiography of diastolic function
LV inﬂow parameters assessed by pulsed wave
Doppler are well established and measure early (E)
and atrial (A) ﬁlling wave velocities, E/A ratio,
deceleration time of early ﬁlling, and isovolumetric
relaxation time [21]. The pulmonary venous inﬂow
pattern into the left atrium is helpful in distinguishing
between normal and pseudonormal mitral inﬂow
patterns, according to the predominance of systolic
velocity (S wave) or diastolic velocity (D wave),
respectively [21].
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motion of the mitral annulus or basal LV myocardial
velocities by ﬁxing the sample in these sites. In
healthy persons the mitral annulus motion is almost a
mirror image of the transmitral inﬂow pattern [19].
Mitral annulus or basal LV myocardial systolic (Sm),
early diastolic (Em) and late diastolic (Am) velocities
correlate well with standard mitral and pulmonary
vein inﬂow patterns of diastolic function.
Echocardiography of mitral regurgitation
2D Doppler TTE and transesophageal echocardiog-
raphy (TEE) allow accurate determination of the
cause and severity of MR. MR severity assessment is
a very complex measure that takes into account a set
of parameters such as regurgitant volume and frac-
tion, colour Doppler regurgitant jet area and jet/left
atrial area ratio, vena contracta width measurement
(narrowest portion of the jet) and proximal isoveloc-
ity surface area (PISA) measurement. In ideal con-
ditions, colour Doppler jet area and jet/left atrial area
ratio used for assessing the severity of MR have high
sensitivity and speciﬁcity as compared with conven-
tional angiography; vena contracta measurements
correlate well with regurgitant volume and regurgit-
ant oriﬁce area, and a high correlation exists between
the regurgitant volume as assessed by the PISA
method and angiography [53]. Additional indirect
clues like pulmonary venous and LV inﬂow patterns,
and left atrial size provide supplementary information
regarding severity of MR. TEE, when compared to
TTE, is less limited by chest structures attenuation,
but TEE is semi-invasive.
Echocardiography of left ventricular mechanical
dyssynchrony
Mechanical dyssynchrony can be assessed using M-
mode and conventional pulsed Doppler TTE, TDI,
strain rate imaging (SRI), and tissue synchronization
imaging (TSI). Strain can be deﬁned as change in the
length per unit length much like relative shortening.
Interventricular dyssynchrony or ‘‘Interventricular
mechanical delay’’ (IVMD) (Fig. 1) is the difference
between the left and right ventricular pre-ejection
time intervals, measured from the onset of the QRS
complex to the beginning of aortic and pulmonary
Doppler ﬂow velocity curves [54]. An IVMD of
40 ms or more represents interventricular dyssyn-
chrony [55–57]. The predictive value of IVDM is
weak, as multiple factors inﬂuence ventricular ejec-
tion, including changes in preload and afterload. In
particular, prolonged RV pre-ejection time interval in
pulmonary hypertension and RV dysfunction reduce
the IVDM accuracy [56].
Intraventricular dyssynchrony has been deﬁned by
three conventional parameters: (1) LV pre-ejection
time interval delays larger than or equal to 140 ms
[54, 57, 58]; (2) Post-systolic contraction or delayed
activation of the lateral wall (co-existence of systole
and diastole) (Fig. 2) measured by overlap of the LV
lateral wall contraction (by using M-mode) and onset
of diastolic ﬁlling (by using transmitral Doppler E-
wave onset), that strongly suggests severe intraven-
tricular dyssynchrony [37] and (3) Septal-to-posterior
wall motion delay (Fig. 3) that measures the time
between maximal displacement of the septum and
posterior wall on M-mode, with a delay that is larger
Fig. 1 Two-dimensional echocardiographic image of a sixty
three years old male, candidate to cardiac resynchronization
therapy, presenting interventricular dyssynchrony shown by
interventricular mechanical delay with a difference between
the (a) aortic pre-ejection time and (b) pulmonar pre-ejection
time, which was >40 ms
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rical and pathophysiological limitations exist that
may render these echocardiographic measures inac-
curate [60].
Intraventricular electromechanical delay is evalu-
ated by longitudinal segmental myocardial contrac-
tion at TDI from apical 4, 3, and 2 chamber views.
Either time-to-peak systolic velocity or time-to-onset
of systolic velocity are measured relative to the
beginning of the QRS complex. Intraventricular LV
dyssynchrony is quantiﬁed either by the standard
deviation of 12 segments (Ts-SD-12 or dyssynchrony
index) or the maximal temporal difference between
two (Ts-2, EMD-2) or more LV segments (e.g. Ts-6,
Ts-12). Larger values of any parameter indicate more
severe dyssynchrony [32]. A mechanical delay
between the septum and the lateral wall of 65 ms
on tissue TDI (Fig. 4) has been found as cut-off value
predictor for response to CRT [54].
The tissue synchronization imaging software auto-
matically measures the time-to-peak systolic velocity,
colour codes delays and then superimposes colour
mapping on real-time 2D images. Colour-coded
display of myocardial displacement allows immediate
visual identiﬁcation of regional delay that ranges
from green (normal) to red (severe delay) and permits
Fig. 2 Echocardiographic image of a sixty eight years old
female, candidate to cardiac resynchronization therapy, show-
ing a post-systolic contraction or delayed activation of lateral
wall (co-existence of systole and diastole), measured by
overlap of the LV lateral wall contraction (by using M-mode)
and onset of diastolic ﬁlling (by using transmitral Doppler
E-wave onset)
Fig. 3 M-mode echocardiographic image of a ﬁfty three years
old female, candidate to cardiac resynchronization therapy,
showing septal-to-posterior wall motion delay (>140 ms).
Fig. 4 Tissue Doppler
Image echocardiography of
74-years-old male,
candidate to cardiac
resynchronization therapy,
showing mechanical delay
between (a) the
interventricular septum and
(b) the lateral left
ventricular wall, that was
>65 ms
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TDI has similar limitations as conventional Doppler
imaging. Notably, the angle between the incident
ultrasound beam and vector of myocardial motion
inﬂuences measurements, and excessive gain causes
spectral broadening and velocity overestimation [32].
Strain rate imaging by speckle tracking can overcome
several limitations of TDI by measuring localized
myocardial deformation that distinguishes passive
and active systolic contraction, although the repro-
ducibility of this technique remains limited [61–64].
The primary objective of CRT is to restore the
normal ventricular activation pattern. Several studies
have shown that the presence of intraventricular
dyssynchrony is a major predictor of response to CRT
[16, 40, 65]. It is important to match the pacing site
with the area of maximum mechanical delay. Pacing
at the site of maximal time-to-peak myocardial
velocity in patients with HF and LV dyssynchrony
has been associated with good clinical response after
CRT. However, delay in peak myocardial velocities
in the antero-septal area has been associated with a
failure of CRT response. The site of latest activation
is predictive for the success of CRT response and
individually tailored LV lead positioning should be
considered before CRT [66]. Real-time 3D echocar-
diography allows rapid and accurate evaluation of LV
volumes and their changes, having a great potential
for assessment of LV dyssynchrony, and allows
determining dyssynchrony between all segments [67].
Phase analysis of segmental volume-time curves
based on 3D data demonstrates changes of regional
myocardial motion and LV contraction pattern in a
quantitative way [68]. However, deﬁning and expres-
sion the delay remains an important issue that
necessitates standardization.
Cardiac CT angiography
General considerations
Since the ﬁrst report concerning non-invasive coro-
nary imaging with electron beam computed tomog-
raphy angiography published in 1995, cardiac
computed tomography techniques have improved
rapidly. Nowadays 64-slice multi-detector-row com-
puted tomography (MDCT) systems are available,
offering good diagnostic image quality with short
acquisition times [69, 70]. Because a regular rhythm
and low heart rate are essential for high-quality
images, b-blockers are usually administered before
the examination. MDCT provides information con-
cerning the coronary arteries and veins, LV volumes
and function as well as myocardial tissue perfusion,
while requiring the use of iodinated contrast agents
[6]. Use of iodinated contrast agents is of concern in
patients with impaired renal function. Furthermore,
MDCT coronary angiography is associated with an
effective radiation dose that varies between 8 and
21 mSv, with or without prospective tube current
modulation [69, 71, 72].
MDCT of left ventricular systolic dysfunction
and remodelling
MDCT is a three-dimensional (3D) imaging modality
that is used for evaluation of ventricular function with
high accuracy and precision [7]. ECG-synchronized
MDCT allows fast and (semi)automatic determina-
tion of LV systolic global function, with LV param-
eters such as LV volumes and LVEF with high
accuracy [7, 73]. Also, RV systolic function can be
accurately assessed by MDCT [74]. MDCT LV
regional wall function analysis at rest is feasible
[75], although further improvements in temporal
resolution are needed to match the results as obtained
from cine MRI [8].
MDCT of the coronary arteries
The majority of potential CRT candidates have
suspected or known coronary artery disease, justifying
coronary artery evaluation before CRT. As compared
to conventional coronary angiography, 64-slice
MDCT is an accurate and non-invasive method to
detect and quantify obstructive and non-obstructive
coronary artery disease [69, 70], (Fig. 5) although the
quantiﬁcation of luminal obstruction is limited due to
technical restrictions. On a patient basis it has been
found that the sensitivity for identifying patients with
stenoses that required angioplasty or bypass surgery
was 94% [75]. MSCT has currently a signiﬁcantly
higher accuracy for detecting or excluding signiﬁcant
coronary artery disease than 1.5 T MRI systems [76].
Experimental and patient studies have shownthat with
delayed enhancement MDCT techniques, the location
and extent of myocardial scar tissue can be accurately
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[77, 78].
MDCT of the coronary veins
The clinical potential of MDCT to disclose the
coronary venous system anatomy (Fig. 6) has been
recognized and advocates its applications for CRT
candidates [79] .I tm a yh e l pi np r e d i c t i n gt h e
technical difﬁculty, selecting the appropriate equip-
ment, and identifying the venous tributary with
appropriate diameter in the region of latest LV
activation, where the LV lead should ideally be
positioned. It may also identify patients who do not
have adequate venous side branches available or
patients who have obstruction and ostial narrowing
(e.g., by a thebesian valve)—these patients are
potential candidates for epicardial lead placement
using a minimal invasive surgical approach [49, 80,
81]. MDCT studies have shown that the posterior
vein of the LV and the left marginal vein were absent
in 5% and 39% of patients, respectively, and
variation in venous drainage patterns largely agrees
with the results of anatomic studies [80, 82, 83].
Fig. 5 Multi-detector computed tomography coronary angi-
ography acquired with 0.5 mm collimation and half-scan
reconstruction (Toshiba Aquilion 64 CT-scanner) in a 66-
years-old male patient showing normal coronary arteries (a)
and in a sixty six years old male patient showing coronary
artery disease (b). The left anterior descending (LAD) coronary
artery and a diagonal branch (D) are visualized in both patients.
Note the irregular lumen of the LAD that was heavily calciﬁed
in the patient with coronary artery disease (b). Curved
multiplanar reconstructions of the diseased LAD that displays
the artery in a single image is shown in two perpendicular
longitudinal directions
Fig. 6 Multi-detector computed tomography angiography
(0.5 mm collimation and half-scan reconstruction, sixty six
years old male patient). Volume rendering images showing the
coronary venous system. CS = coronary sinus; GCV = great
cardiac vein; AIV = anterior interventricular vein; LMV = left
marginal vein; PIV = posterior interventricular vein;
OM = obtuse marginal coronary artery branch; RCA = right
coronary artery
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General considerations
MRI provides accurate morphological and functional
analysis irrespective of the patient’s anatomy [84].
The technique is non-invasive and most gadolinium-
chelate contrast agents are less toxic than iodinated
contract agents used for CT. However, MRI is not
feasible in all patients; claustrophobia is occasionally
a problem, and absolute contraindications include
cerebral clips, pacemakers, and deﬁbrillators [85],
although some modern pacemakers and deﬁbrillators
have shown MRI compatibility in experimental
studies [86, 87].
MRI of left ventricular systolic dysfunction
remodelling
3D-cine MRI is performed in any volume desirable
without geometrical assumptions. The technique has
excellent temporal and good spatial resolution,
showing high accuracy and reproducibility for quan-
tifying LV volumes and function [7]. Currently, this
is achieved using fast gradient-echo sequences
(Fig. 7). Thirty to forty cardiac phases are obtained
with a time resolution of less than 40 ms [88].
MRI myocardial tagging (Fig. 8) concerns a
method where the myocardium is labelled (tagged)
by selective saturation prepulses in speciﬁc myocar-
dial regions in planes perpendicular to the imaging
plane. The tags appear as a pattern of horizontal and
vertical lines, forming a grid superimposed on the
image. The analysis of tag deformation enables
quantiﬁcation of global and regional myocardial
deformation during the cardiac cycle. The tagging
technique is most applied in ischemic heart disease
[89].
MRI of diastolic dysfunction
Cardiac MRI is emerging as a powerful and non-
invasive technique with the unique potential of 3D
analysis of diastolic function [90]. Phase-contrast or
velocity encoded MRI permit quantiﬁcation of ﬂow
across the mitral valve, providing E and A peak
velocities and volume [91–93] and identiﬁcation of
the pulmonary venous S wave, D wave and atrial
reversal wave components, in close agreement with
that of Doppler echocardiography [91]. 2D echocar-
diography methods may limit obtaining correct ﬂow
velocity proﬁles [94, 95]. This is not the case with 3D
MRI techniques.
Analogous to ﬂow velocities, velocity encoded
MRI allows measurement of tissue velocities. In each
myocardial voxel, the strain rate can be quantiﬁed
[96]. Tissue MRI is a feasible method to assess septal
tissue velocities (Ea). The combination of E and Ea
allows the estimation of ﬁlling pressure, comparable
to Doppler echocardiography. MRI measurements
have shown good agreement with invasive measure-
ments [97].
Fig. 7 Magnetic resonance imaging in a 20-year-old healthy
male. Short-axis images at left midventricular level. Functional
imaging (balanced turbo ﬁeld-echo sequence with TR 3.8 ms,
TE 1.9 ms, ﬂip angle 708, slice thickness 8 mm) at end-
diastolic (a) and end-systolic (b) time points. Note the equal
circular contraction of the left ventricular wall. Ejection
fraction was 60%
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tion throughout the cardiac cycle allows accurate
analysis of diastolic strain and 3D cardiac motion
(rotation, radial contraction, and translation) with high
temporal resolution of about 40 ms [98]. Echocardio-
graphic images do not allow this 3D reconstruction
and quantiﬁcation because of the absence of reference
points within the myocardium, ultrasound beam
parallel alignment difﬁculties with moving myocar-
dium, and poor epicardial visualization [92]. On the
other hand, the novel speckle tracking techniques
might overcome this limitation [99].
MRI of mitral regurgitation
The mitral regurgitant fraction volume can be
quantiﬁed with high accuracy by MRI, either
directly by velocity mapping in the valvular plane
(regurgitant fraction = forward/backward ﬂow), or
as a difference between LV stroke volume obtained
by volumetric quantiﬁcation and ejected volume in
the proximal ascending aorta, assessed by velocity
encoded MRI [100]. One-directional velocity-en-
coded MRI methods may lack accuracy, as the
regurgitant jet may not be directed perpendicular to
the imaged valvular plane. To overcome this
problem, 3 directional blood ﬂow vector velocity
imaging has been developed, providing accurate
and reproducible transvalvular mitral valve ﬂow
quantiﬁcation [101] (Fig. 9).
MRI of left ventricular mechanical dyssynchrony
Presently, the method of choice for assessing LV
mechanical dyssynchrony is TDI-echocardiography
[102–105]. Several topics regarding the assessment of
LV dyssynchrony remain unclear, such as the level of
the ventricle where to assess dyssynchrony, and the
number of ventricular wall segments requiring
assessment. A compromise is necessary between
optimal detection of mechanical delay and feasibility
of examining numerous segments in clinical practice.
Interrogation of only two segments may overlook a
signiﬁcant proportion of delayed myocardium, thus
inadequately assessing dyssynchrony [33]. At yet
Fig. 9 Example of ﬂow velocity reconstruction through the
mitral valve plane from 3-directional velocity-encoded MRI.
During systole, the regurgitant jet is clearly presented. During
diastole, the inﬂow is visualized
Fig. 8 Magnetic resonance imaging in a 22-years-old healthy
male. Short-axis tagging imaging at left midventricular level
with echo-planar imaging (EPI) tagging sequence with EPI
factor 7, TR 30 ms, TE 13 ms, ﬂip angle 208, slice thickness
8 mm, at end-diastolic (a) and end-systolic (b) time points.
Vector motion analysis of tagging points throughout the
cardiac cycle allows left ventricular strain rate analysis
98 Int J Cardiovasc Imaging (2008) 24:89–105
123there is no ideal echocardiographic mechanical
dyssynchrony indicator, and this evaluation in
patients with narrow QRS is currently not indicated.
The echocardiographic parameters of dyssynchrony
are not robust enough to withhold CRT, with proven
morbidity and mortality [55]. A change of guidelines
has already been proposed by some authors [5] while
for others it is neither mandatory to alter current
guidelines for patient selection nor essential to
include echocardiographic assessment [55]. Most
echocardiographic mechanical dyssynchrony analysis
methods are based on longitudinal motion data [66].
However, cardiac contraction is mainly radial, and
the longitudinal motion data in patients with HF may
not provide the most accurate and comprehensive LV
dyssynchrony data.
MRI has the potential to evaluate mechanical
dyssynchrony either by tagging or velocity-encoded
MRI [106]. Quantitative strain analysis based on 3D
circumferential and longitudinal myocardial activa-
tion data has high spatial and temporal resolution, and
has shown high reproducibility. Moreover, MRI data
acquisition is largely operator and patient indepen-
dent and may thus be better suited to characterize
dyssynchronous HF and to identify appropriate
candidates for CRT than Doppler echocardiographic
methods. MRI myocardial tagging [96, 107, 108] can
be used to calculate local myocardial motion or
strain. Advances in the rapid analysis of tagged
magnetic resonance images such as harmonic phase
(HARP) and strain-encoded (SENC) imaging, and the
design of novel global indexes of cardiac dyssyn-
chrony may provide a more comprehensive method
for selecting candidates for CRT. The HARP method
measures the motion from tagged MR images by
ﬁltering certain regions in the frequency domain of
the images called harmonic peaks [109, 110]. The
HARP method measures the local strain of tissue by
measuring the frequency of the tag lines. The number
of tags per unit length is called the frequency of the
tag pattern. If this tissue contracts, the tag lines
become closer to each other and the tag frequency
increases in proportion to the contraction, and vice
versa. Circumferential strain in a given angular sector
of each slice is then plotted during the cardiac cycle
[106]. The new technique SENC imaging is derived
from a standard myocardial tagging sequence that
tags the tissue at end-diastole with a sinusoidal tag
pattern designed to modulate the longitudinal
magnetization orthogonal to the imaging plane.
Deformations of tissue during systole will change
the local frequency of the pattern in proportion to the
through-plane strain component. The distribution of
regional contraction (circumferential shortening in
long-axis views or longitudinal compression in short-
axis views) is then displayed as contrast in the
images. The SENC technique has several features
that are well suited for assessing dyssynchronous HF
and CRT, as it provides: (1) Instantaneous real-time
quantitative strain measurements without the need for
user intervention; (2) Higher spatial resolution over
standard tagging as a result of reduced tag spacing;
(3) Acquisition of both circumferential and longitu-
dinal myocardial stain information; and (4) Assess-
ment of regional function of both ventricles.
Velocity-encoded MRI, when applied for myocar-
dial wall motion measurement [111, 112], potentially
allows direct myocardial wall motion measurement
similar to TDI (i.e., comparing velocity graphs
obtained in different parts of the myocardial wall
during systole). In a study where velocity-encoded
MRI was compared to TDI, a strong correlation for
LV dyssynchrony assessment was found between
these two techniques. Moreover, agreement was
excellent when patients were categorized according
to severity of LV dyssynchrony (minimal, interme-
diate, or extensive): 95% of patients were equally
classiﬁed with MRI and TDI [113]. These initial
results show that MRI can provide similar informa-
tion on LV dyssynchrony as TDI. Besides measuring
longitudinal myocardial wall velocities (basal-to-
apex contraction and relaxation) in four-chamber
orientation, MRI can also provide the longitudinal
myocardial wall velocity acquired in short-axis
orientation [114]. Dividing the circumference of the
short axis into multiple segments and measuring the
time of peak systolic velocity in each of these
segments indicates the site of latest activation.
Finally, LV dyssynchrony can also be determined
from wall thickening and wall thinning measurements
in short-axis MRI (Fig. 10). The standard 16-segment
model can be used. At short-axis imaging the basal
level and mid-ventricular level are divided into six
segments each. The apical level is divided into four
segments. The endocardial and epicardial contours
are determined in all phases [115]. For each of the 16
segments, the times to peak wall thickening and peak
wall thinning are acquired. The means and standard
Int J Cardiovasc Imaging (2008) 24:89–105 99
123deviations are determined. A large standard deviation
indicates a large spread in contraction patterns, thus
more LV dyssynchrony.
MRI of myocardial ischemia and viability
Stress echocardiography and scintigraphic techniques
are useful in clinical practice with wide availability
for assessing ischemia, perfusion and viability.
However, non-diagnostic echocardiography examin-
ations are reported in 10–15% of cases, mostly due to
limited image quality and due to the fact that
examinations are observer dependent [116]. Scinti-
graphic exams are sufﬁcient reproducible but limita-
tion in spatial resolution reduce sensitivity, while
attenuation artefacts compromise speciﬁcity, whereas
the radiation burden is also of concern [117]. MRI
visualizes global and regional wall motion and
systolic wall thickening with a high spatial and
temporal resolution. Wall motion abnormalities can
be detected at rest and high dose dobutamine stress
with high rate of diagnostic accuracy, superior to that
of dobutamine stress echocardiography. Cine loops of
cardiac motion are acquired with steady state free
precession gradient-echo techniques, where the imag-
ing contrast is generated by the difference in mag-
netization between the blood and myocardium. MRI
is especially beneﬁcial in patients who have
insufﬁcient acoustic window [116]. First-pass perfu-
sion MRI with excellent spatial and temporal reso-
lution is currently the most accurate method for
non-invasive assessment of myocardial perfusion
[117].
Delayed contrast-enhanced MRI is extremely
valuable for assessing viable and nonviable myocar-
dium in infarcted and poorly contracting myocardial
areas (Fig. 11).
Contrast-enhanced MRI enables depiction of
transmural and non-transmural infarctions with better
spatial and contrast resolution and better accuracy
than scintigraphic techniques [118]. Combined
assessment of scar tissue and LV dyssynchrony is
needed to optimize prediction of response to CRT. It
has been found that patients with transmural scar
tissue in the posterolateral LV wall did not respond to
CRT, even if extensive LV dyssynchrony existed. On
the other hand, patients with non-transmural scar
tissue in the same segments and with severe baseline
LV dyssynchrony, showed excellent response (95%)
after CRT [119].
Conclusion
The well known efﬁcacy of CRT, its high cost and
signiﬁcant percentage of non-responders justiﬁes
Fig. 10 Example of LV
dyssynchrony
measurements in a healthy
volunteer (A,B) and a
patient with extensive
dyssynchrony (C, D). In A
and C, the longitudinal
velocities measured with
MRI are presented. Sample
volumes are placed in septal
and lateral wall at the basal
level. The mean velocities
measured in these sample
volumes are presented in B
and C.I nB, the peak
systolic velocities of septal
and lateral wall coincide. In
D, a large delay between
peak systolic velocities in
septal and lateral wall of
115 ms is present
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123evaluation of the potential and applicability of the
various imaging modalities for improved patient
selection. Echocardiography has been the most fre-
quently used technique and its potential has been
fully explored. However, an ideal parameter repre-
senting mechanical dyssynchrony has not been
recognised yet and there are some obstacles to the
acquisition of data using echocardiography. As
compared to echocardiography, cardiac MDCT and
MRI are 3D techniques not limited by geometric
assumptions, and less operator dependent. Use of
cardiac MDCT can be mainly advantageous for non-
invasively assessing the status of coronary arteries
and veins and identifying whether or not patients
have a suitable coronary vein for transvenous CRT
LV lead placement. MDCT can also be used for
determining LVEF and ventricular volumes either for
CRT patient selection or follow-up CRT. The role for
MDCT in assessing mechanical dyssynchrony, dia-
stolic function, and mitral regurgitation seems limited
due to the current limitation in temporal resolution
and inability to measure ﬂow directly.
Cardiac MRI has currently the greatest potential
for improved assessment of patients who are candi-
dates for CRT as it provides the unique capabilities to
study many aspects of cardiac anatomy, ventricular
and valvular regurgitant volumes, systolic and dia-
stolic function, ischemia and viability in a single
imaging session. Moreover, MRI has the potential to
identify CRT responders by evaluating LV dyssyn-
chrony and myocardial scarring, which can assist in
the selection of the optimal CRT pacing site. After
having decided, based on echocardiography or MRI,
that the patient is a potential candidate for CRT,
MDCT may be used for depicting or excluding
coronary artery disease and assessing the route for
pacemaker lead implantation. Integrated imaging data
provide a roadmap to the cardiologist to optimize the
prediction of CRT response and potentially minimize
inherent risks to the procedure.
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